Company Presentation
Basilea Pharmaceutica International Ltd, Allschwil
| Country: | Switzerland |
| Category: | Advanced Biotech Company |
| Room: | Osaka |
| Date: | 22.04.2024. |
| Time: | 14:45-15:00 |
| Website: | basilea.com |
| Speaker: | Laurenz Kellenberger, Ph.D., Chief Scientific Officer at Basilea Pharmaceutica International Ltd, Allschwil |
Company profile
Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in Switzerland. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial or fungal infections. We have successfully launched two hospital brands, Cresemba and Zevtera. In addition, we have preclinical and clinical anti-infective assets in our portfolio. Basilea is listed on the SIX Swiss Exchange (SIX: BSLN).
